Antiviral treatment selection for SARS-CoV-2 pneumonia
M Bassetti, S Corcione, S Dettori… - Expert Review of …, 2021 - Taylor & Francis
Introduction Therapy of coronavirus disease 2019 (COVID-19) involves evolving algorithms
that include drugs aimed at reducing disease progression by counteracting two different, but …
that include drugs aimed at reducing disease progression by counteracting two different, but …
Addressing the 'hypoxia paradox'in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
Abstract Background Since fall 2019, SARS-CoV-2 spread world-wide, causing a major
pandemic with estimated~ 220 million subjects affected as of September 2021. Severe …
pandemic with estimated~ 220 million subjects affected as of September 2021. Severe …
[HTML][HTML] Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis
SH Liao, CC Hung, CN Chen, JY Yen, CY Hsu… - Journal of the Formosan …, 2021 - Elsevier
Background/purpose A synthesis design and multistate analysis is required for assessing
the clinical efficacy of antiviral therapy on dynamics of multistate disease progression and in …
the clinical efficacy of antiviral therapy on dynamics of multistate disease progression and in …
[PDF][PDF] Managing therapeutic uncertainty in the COVID-19 pandemic: rapid evidence syntheses and transparent decision-making
Managing therapeutic uncertainty in the COVID-19 pandemic: rapid evidence syntheses and
transparent decision-making Page 1 41 Managing therapeutic uncertainty in the COVID-19 …
transparent decision-making Page 1 41 Managing therapeutic uncertainty in the COVID-19 …
[HTML][HTML] Implementing living evidence to inform health decisions: A strategy for building capacity in health sector (Protocol)
MX Rojas-Reyes, GU Chuchí, G Rada… - Open Research …, 2021 - ncbi.nlm.nih.gov
Every day important healthcare decisions are made with incomplete or outdated information
about the effects of the healthcare interventions available, what delivers the best value for …
about the effects of the healthcare interventions available, what delivers the best value for …
[HTML][HTML] Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area
AG Njuguna, AW Wangombe, MN Walekhwa… - medRxiv, 2024 - ncbi.nlm.nih.gov
This study aims to investigate the clinical course and factors associated with hospital
admission and mortality among SARS-CoV-2 patients within the Nairobi Metropolitan Area …
admission and mortality among SARS-CoV-2 patients within the Nairobi Metropolitan Area …
Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report
D Vukoja, A Jurić, Z Erkapić, T Pejić, Ž Zovko… - Frontiers in …, 2021 - frontiersin.org
Even in 2021, coronavirus disease 2019 (COVID-19) remains a major global health
concern, especially in developing countries. The burden of this disease, caused by severe …
concern, especially in developing countries. The burden of this disease, caused by severe …
Predictors of mortality in acute hospitalised COVID-19 pneumonia patients: A retrospective cohort study at two tertiary-level hospitals in Zambia
J Banda, A Mweemba, T Bulaya, N Chenga… - South African Medical …, 2022 - journals.co.za
Background The global COVID-19 pandemic has resulted in increased acute
hospitalisations, a high demand for intensive care and high in-hospital mortality, placing a …
hospitalisations, a high demand for intensive care and high in-hospital mortality, placing a …
SARS-CoV-2 Spike Protein: A Review of Structure, Function, Care, Vaccines, and Possible Inhibitors Designed by Molecular Modeling
TAM Coelho, RC Silva, SQ Gomes… - Trends and Innovations …, 2024 - Springer
Abstract In Wuhan, Hubei Province, China, a new species of coronavirus has emerged,
defined as SARS-CoV-2, which causes severe acute respiratory syndrome, COVID-19 …
defined as SARS-CoV-2, which causes severe acute respiratory syndrome, COVID-19 …
[PDF][PDF] Inhalation therapy as a mode of home remedial treatment of COVID-19 in Bangladesh
MDS Ahmed, R Basri, M Montaha… - Journal of Medicinal …, 2022 - researchgate.net
Abstract COVID-19 (for coronavirus disease 2019) is the name given to the current
pandemic sweeping the world and which started in Wuhan, China at the tail end of …
pandemic sweeping the world and which started in Wuhan, China at the tail end of …